– Funding of $9.9 million by Department of Defense, Congressionally Directed Medical Research Programs to discover new treatments for TB
– Collaboration leverages unique genetic expertise and X-Chem’s proprietary DEXTM Platform to identify novel drugs against the deadly infectious disease
To read the full press release, click here.
Source: X-Chem, Inc.